Due to these previous findings, a challenge infection was not performed in our study, instead, we considered the simultaneous analysis of PRRSV-specific IFN-γ producing lymphocytes and nAbs (see also below) as adequate read-outs to evaluate vaccine efficacy. The gene discussed is IFNG; the disease is infection.